Chlorogenic acid

CAT:
804-HY-N0055-01
Size:
100 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Chlorogenic acid - image 1

Chlorogenic acid

  • UNSPSC Description:

    Chlorogenic acid is a major phenolic compound in Lonicera japonica Thunb. It is an orally active antioxidant activity, antibacterial, hepatoprotective, cardioprotective, anti-inflammatory, antipyretic, neuroprotective, anti-obesity, antiviral, anti-microbial, anti-hypertension compound[1][2][3].
  • Target Antigen:

    Bacterial; Endogenous Metabolite; HIF/HIF Prolyl-Hydroxylase; Influenza Virus; Reactive Oxygen Species
  • Type:

    Natural Products
  • Related Pathways:

    Anti-infection;Immunology/Inflammation;Metabolic Enzyme/Protease;NF-κB
  • Applications:

    COVID-19-anti-virus
  • Field of Research:

    Cancer; Infection; Inflammation/Immunology; Cardiovascular Disease
  • Assay Protocol:

    https://www.medchemexpress.com/Chlorogenic-acid.html
  • Purity:

    99.55
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic)|H2O : ≥ 20 mg/mL
  • Smiles:

    O=C([C@@]1(O)C[C@@H](OC(/C=C/C2=CC=C(O)C(O)=C2)=O)[C@H](O)[C@H](O)C1)O
  • Molecular Weight:

    354.31
  • References & Citations:

    [1]Park JJ, et al. Chlorogenic acid inhibits hypoxia-induced angiogenesis via down-regulation of the HIF-1α/AKT pathway. Cell Oncol (Dordr). 2015 Jan 6.|[2]Park SH, et al. IRAK4 as a Molecular Target in the Amelioration of Innate Immunity-Related Endotoxic Shock and Acute Liver Injury by Chlorogenic Acid. J Immunol. 2015 Feb 1;194(3):1122-30.|[3]Kang JW, et al. Protective Effects of Chlorogenic Acid against Experimental Reflux Esophagitis in Rats. Biomol Ther (Seoul). 2014 Sep;22(5):420-5.|[4]Huang S, et al. Chlorogenic acid effectively treats cancers through induction of cancer cell differentiation. Theranostics. 2019 Sep 19;9(23):6745-6763.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Clinical Information:

    No Development Reported
  • CAS Number:

    327-97-9